Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
Purpose. To compare the visual and anatomic outcomes in patients with persistent diabetic macular edema (DME) who switched from ranibizumab to aflibercept with those who continued with previous ranibizumab therapy. Methods. In this retrospective comparative study, medical records of consecutive pati...
Saved in:
Main Authors: | Ali Demircan, Zeynep Alkin, Ceren Yesilkaya, Gokhan Demir, Burcu Kemer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2018/4171628 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant
by: Antoine Herbaut, et al.
Published: (2017-01-01) -
Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
by: David R. Griffin, et al.
Published: (2014-01-01) -
Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis
by: Xiaolei Sun, et al.
Published: (2020-01-01) -
Extended Injection Intervals after Switching from Ranibizumab to Aflibercept in Macular Edema due to Central Retinal Vein Occlusion
by: Sylvia Nghiem-Buffet, et al.
Published: (2018-01-01) -
Renal Biomarkers for Treatment Effect of Ranibizumab for Diabetic Macular Edema
by: Ivan Pochou Lai, et al.
Published: (2020-01-01)